Results 161 to 170 of about 14,587 (196)

Clinical and microbiological analyses of colistin-resistant strains among carbapenem-resistant Enterobacter cloacae complex clinical isolates. [PDF]

Microbiol Spectr
Yang J, Baek JY, Ko J-H, Huh K, Cho SY, Chung DR, Peck KR, Huh HJ, Ko KS, Kang C-I.   +9 more
europepmc   +1 more source

Molecular epidemiology and β-lactam resistance mechanisms of <i>Enterobacter cloacae</i> complex isolates obtained from bloodstream infections, Kyoto, Japan. [PDF]

Microbiol Spectr
Matsuo A, Matsumura Y, Mori K, Noguchi T, Yamamoto M, Nagao M.   +5 more
europepmc   +1 more source

Clinical Characteristics and Risk Factors for Multidrug-Resistant Enterobacter cloacae Complex Bacteremia in a Chinese Tertiary Hospital: A Decade Review (2013-2022). [PDF]

Infect Drug Resist
Han M, Hua M, Xie H, Li J, Wang Y, Shen H, Cao X.   +6 more
europepmc   +1 more source

Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae

Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae
openaire  

Molecular Characterization of IMP-1-Producing Enterobacter cloacae Complex Isolates in Tokyo [PDF]

Antimicrobial Agents and Chemotherapy, 2018
Although KPC enzymes are most common among carbapenemases produced by Enterobacter cloacae complex globally, the epidemiology varies from one country to another.
Kotaro Aoki, Sohei Harada, Yoshikazu Ishii   +2 more
exaly   +4 more sources